Home
/
CASTLE BIOSCIENCES INC
/
Financials
/
Quarterly
CASTLE BIOSCIENCES INC — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that CASTLE BIOSCIENCES INC filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$83.04M
Nov 3, 2025
Q2
2025
Jun 30, 2025
$86.19M
Aug 4, 2025
Q1
2025
Mar 31, 2025
$87.99M
May 5, 2025
Q3
2025
Sep 30, 2024
$85.78M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$87.00M
Aug 4, 2025
Q1
2025
Mar 31, 2024
$72.97M
May 5, 2025
Q3
2024
Sep 30, 2023
$61.49M
Nov 4, 2024
Q2
2024
Jun 30, 2023
$50.14M
Aug 5, 2024
Q1
2024
Mar 31, 2023
$42.04M
May 2, 2024
Q3
2023
Sep 30, 2022
$37.01M
Nov 2, 2023
Q2
2023
Jun 30, 2022
$34.84M
Aug 2, 2023
Q1
2023
Mar 31, 2022
$26.85M
May 3, 2023
Q3
2022
Sep 30, 2021
$23.48M
Nov 2, 2022
Q2
2022
Jun 30, 2021
$22.76M
Aug 8, 2022
Q1
2022
Mar 31, 2021
$22.81M
May 9, 2022
Q3
2021
Sep 30, 2020
$15.22M
Nov 8, 2021
Q2
2021
Jun 30, 2020
$12.72M
Aug 9, 2021
Q1
2021
Mar 31, 2020
$17.42M
May 10, 2021
Q3
2020
Sep 30, 2019
$14.77M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$10.74M
Aug 10, 2020
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($501.0K)
Nov 3, 2025
Q2
2025
Jun 30, 2025
$4.52M
Aug 4, 2025
Q3
2025
Jun 30, 2025
$4.52M
Nov 3, 2025
Q3
2025
Mar 31, 2025
($25.85M)
Nov 3, 2025
Q1
2025
Mar 31, 2025
($25.85M)
May 5, 2025
Q2
2025
Mar 31, 2025
($25.85M)
Aug 4, 2025
Q3
2025
Sep 30, 2024
$2.27M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$8.92M
Aug 4, 2025
Q3
2025
Jun 30, 2024
$8.92M
Nov 3, 2025
Q3
2025
Mar 31, 2024
($2.53M)
Nov 3, 2025
Q2
2025
Mar 31, 2024
($2.53M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
($2.53M)
May 5, 2025
Q3
2024
Sep 30, 2023
($6.91M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($18.78M)
Aug 5, 2024
Q3
2024
Jun 30, 2023
($18.78M)
Nov 4, 2024
Q2
2024
Mar 31, 2023
($29.20M)
Aug 5, 2024
Q3
2024
Mar 31, 2023
($29.20M)
Nov 4, 2024
Q1
2024
Mar 31, 2023
($29.20M)
May 2, 2024
Q3
2023
Sep 30, 2022
($20.25M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($1.65M)
Aug 2, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($6.80M)
Nov 3, 2025
Q2
2025
Jun 30, 2025
($4.25M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($27.93M)
May 5, 2025
Q3
2025
Sep 30, 2024
$5.08M
Nov 3, 2025
Q2
2025
Jun 30, 2024
$5.01M
Aug 4, 2025
Q1
2025
Mar 31, 2024
($5.47M)
May 5, 2025
Q3
2024
Sep 30, 2023
($9.64M)
Nov 4, 2024
Q2
2024
Jun 30, 2023
($21.16M)
Aug 5, 2024
Q1
2024
Mar 31, 2023
($31.52M)
May 2, 2024
Q3
2023
Sep 30, 2022
($21.54M)
Nov 2, 2023
Q2
2023
Jun 30, 2022
($3.97M)
Aug 2, 2023
Q1
2023
Mar 31, 2022
($24.52M)
May 3, 2023
Q3
2022
Sep 30, 2021
($11.81M)
Nov 2, 2022
Q2
2022
Jun 30, 2021
($8.81M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($4.28M)
May 9, 2022
Q3
2021
Sep 30, 2020
($3.90M)
Nov 8, 2021
Q2
2021
Jun 30, 2020
($645.0K)
Aug 9, 2021
Q1
2021
Mar 31, 2020
$1.04M
May 10, 2021
Q3
2020
Sep 30, 2019
$4.43M
Nov 9, 2020
Q2
2020
Jun 30, 2019
$608.0K
Aug 10, 2020